Aging is the dominant risk factor underlying most chronic diseases.32 Rather than treating cancer, dementia, heart disease, and frailty as separate phenomena, increasing numbers of influential individuals recognize that most degenerative diseases are downstream consequences of aging biology. And while improved healthspan is an often-stated objective, the benefit of increased lifespan is being recognized as a bridge to future advances in medicine. In other words, individuals today may benefit by engaging in interventions to remain alive long enough to benefit from revolutionary rejuvenation therapies. This is one of several motivating factors that is causing billions of dollars of mostly private money to go toward longevity research… enabling a virtual tsunami of discoveries/innovation.